by
Thomas Dworetzky, Contributing Reporter | December 28, 2017
In 2016 the market was worth $8.01 billion and it’s projected to grow at a 9.3 percent annualized rate and reach $14.99 billion by 2023. North America will dominate the market during the forecast period due to the higher incidences of hypertension, high cholesterol and diabetes in the region.
In addition, research published in the
Journal of Clinical Electrophysiology in October
confirmed that it's safe to use MR to evaluate the heart or lungs in patients with them.
Ad Statistics
Times Displayed: 60070
Times Visited: 5271 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
In the study, researchers from the Intermountain Medical Center Heart Institute studied 212 MR studies from 178 patients with a cardiac implantable device, that took place between February 2014 and August 2016. They found that not a single study required remediation.
"That's a pretty big number of leads exposed to these very strong MRI fields. You would think if there were even a one percent chance of having a problem, it would have shown up," Dr. Jeffrey L. Anderson, senior study author and cardiologist at the institute, said in a statement. "Not even one generator or lead needed more than a minor adjustment, if any at all."
Back to HCB News
